Array Biopharma Inc News Today

The company has confirmed layoffs will begin in October.

Pharmaceutical giant Pfizer Inc. (NYSE: PFE) will shut down its research and development facility in Boulder in the coming months.

Operator: Greetings and welcome to Array Technologies Fourth Quarter and Full Year 2023 Earnings Call. At this time, all participants are in a listen-only mode.

Operator: Greetings and welcome to Array Technologies Third Quarter 2023 Earnings Call. At this time, all participants are in a listen-only mode.

/PRNewswire/ -- Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: The FDA Oncology Center of...

Pfizer Inc. is laying off an unspecified number of workers in its Boulder research and development operation.

BioLoomics Inc., a Boulder-based life-sciences startup, has raised $8.7 million in seed financing.

The bile duct cancer drug market embodies the pinnacle of oncology research and precision medicine, targeting a formidable malignancy that affects the bile ducts, which play a crucial role in digestion and metabolism. Bile duct cancer, or cholangiocarcinoma, presents unique challenges due to its location and limited treatment options. This technology encompasses a spectrum ofThe bile duct cancer drug market embodies the pinnacle of oncology research and precision medicine, targeting a formidable...

Dublin, Aug. 02, 2023 (GLOBE NEWSWIRE) -- The "Bladder Cancer Drugs Global Market Report 2023" report has been added to ResearchAndMarkets.com's...

Global Bladder Cancer Drugs Market Global Bladder Cancer Drugs Market Dublin, Aug. 02, 2023 (GLOBE NEWSWIRE) -- The "Bladder Cancer Drugs Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. The global bladder cancer drugs market is witnessing robust expansion, with a projected value of $2.66 billion in 2023, rising from $2.32 billion in 2022. This impressive growth is driven by a compound annual growth rate (CAGR) of 14.4%. The market is expected...